---
title: "Guangzhou Kingmed Diagnostics Group Co.,Ltd (603882.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603882.SH.md"
symbol: "603882.SH"
name: "Guangzhou Kingmed Diagnostics Group Co.,Ltd"
industry: "Health Care Services"
datetime: "2026-05-20T18:38:04.975Z"
locales:
  - [en](https://longbridge.com/en/quote/603882.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603882.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603882.SH.md)
---

# Guangzhou Kingmed Diagnostics Group Co.,Ltd (603882.SH)

## Company Overview

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | CN Market |
| Website | [www.kingmed.com.cn](https://www.kingmed.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.57)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 8 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -13.20% |  |
| Net Profit YoY | 73.70% |  |
| P/B Ratio | 1.91 |  |
| Dividend Ratio | 3.36% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12158955606.26 |  |
| Revenue | 5925446656.04 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.55% | D |
| Profit Margin | -1.74% | D |
| Gross Margin | 34.90% | C |
| Revenue YoY | -13.20% | E |
| Net Profit YoY | 73.70% | A |
| Total Assets YoY | -6.64% | D |
| Net Assets YoY | -7.62% | D |
| Cash Flow Margin | -1159.99% | E |
| OCF YoY | -13.20% | E |
| Turnover | 0.62 | B |
| Gearing Ratio | 29.54% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Guangzhou Kingmed Diagnostics Group Co.,Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-13.20%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "73.70%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.91",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "3.36%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12158955606.26",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "5925446656.04",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.55%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-1.74%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "34.90%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-13.20%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "73.70%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-6.64%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-7.62%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-1159.99%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-13.20%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.62",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "29.54%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -117.00 | 8/8 | - | - | - |
| PB | 1.89 | 4/8 | 2.09 | 1.99 | 1.90 |
| PS (TTM) | 2.03 | 3/8 | 2.31 | 2.14 | 2.02 |
| Dividend Yield | 3.39% | 1/8 | 3.28% | 3.08% | 2.87% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | TC Medical (600763.SH) | B | C | C | B | C | B |
| 02 | HESH (301103.SZ) | C | C | C | A | B | B |
| 03 | Meinian Onehealth (002044.SZ) | C | D | C | C | B | C |
| 04 | Kingmed Diagnostics (603882.SH) | D | D | B | B | E | C |
| 05 | Dian Diagnostics (300244.SZ) | C | D | B | B | C | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-05T16:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 63% |
| Hold | 1 | 13% |
| Sell | 2 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 25.93 |
| Highest Target | 36.62 |
| Lowest Target | 22.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603882.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603882.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603882.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603882.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**